WHO ICTRP trial
Effect of on combination therapy with irbesartan and amlodipine besilate on…
JPRN-UMIN000013213 · Japan Primary Registries Network (JPRN) · Recruiting
Key facts
| Trial ID | JPRN-UMIN000013213 |
|---|---|
| Public title | Effect of on combination therapy with irbesartan and amlodipine besilate on clinical blood pressure, home blood pressure and blood pressure variability in hypertensive patients with chronic kidney disease |
| Scientific title | Effect of on combination therapy with irbesartan and amlodipine besilate on clinical blood pressure, home blood pressure and blood pressure variability in hypertensive patients with chronic kidney disease - Effect of combination therapy with irbesartan and amlodipine besilate on hypertensive… |
| Primary sponsor | Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | Not selected |
| Countries | Japan |
| Conditions | Hypertension with chronic kidney disease (CKD G1-G4) |
| Interventions | Irbesartan / amlodipine besilate combination tablets |
| Registration date | Feb 21, 2014 |
| Target size | 30 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: